167 related articles for article (PubMed ID: 37879213)
1. PLK1 regulating chemoradiotherapy sensitivity of esophageal squamous cell carcinoma through pentose phosphate pathway/ferroptosis.
Zhao M; Lu T; Bi G; Hu Z; Liang J; Bian Y; Feng M; Zhan C
Biomed Pharmacother; 2023 Dec; 168():115711. PubMed ID: 37879213
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel.
Yan J; Shi L; Lin S; Li Y
Bioengineered; 2021 Dec; 12(1):5334-5347. PubMed ID: 34415232
[TBL] [Abstract][Full Text] [Related]
4. Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma.
Chen Q; Zhang L; Wan C; Yang B; Kong X; Xu X; Gu Y; Wang C; Liu X; Ding Q; Zhu L; Li Y; Wang B; Zhong W
Int J Oncol; 2023 Jul; 63(1):. PubMed ID: 37203411
[TBL] [Abstract][Full Text] [Related]
5. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.
Li DJ; Shi M; Wang Z
Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776
[TBL] [Abstract][Full Text] [Related]
6. SCARA5 induced ferroptosis to effect ESCC proliferation and metastasis by combining with Ferritin light chain.
Liu Y; Xiong R; Xiao T; Xiong L; Wu J; Li J; Feng G; Song G; Liu K
BMC Cancer; 2022 Dec; 22(1):1304. PubMed ID: 36513999
[TBL] [Abstract][Full Text] [Related]
7. YY1 modulates the radiosensitivity of esophageal squamous cell carcinoma through KIF3B-mediated Hippo signaling pathway.
Zheng C; Li Z; Zhao C; Yin X; Feng L; Wang Z; Liu C; Li B
Cell Death Dis; 2023 Dec; 14(12):806. PubMed ID: 38065955
[TBL] [Abstract][Full Text] [Related]
8. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.
Cao YY; Yu J; Liu TT; Yang KX; Yang LY; Chen Q; Shi F; Hao JJ; Cai Y; Wang MR; Lu WH; Zhang Y
Cell Death Dis; 2018 Jan; 9(2):17. PubMed ID: 29339720
[TBL] [Abstract][Full Text] [Related]
9. Gliotoxin Induced Ferroptosis by Downregulating SUV39H1 Expression in Esophageal Cancer Cells.
Zhang S; Guo J; Zhang H; Tong L; Zhang L
Recent Pat Anticancer Drug Discov; 2023; 18(3):397-407. PubMed ID: 36065932
[TBL] [Abstract][Full Text] [Related]
10. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms].
Zhu ZQ; Hu HF; Zheng XY; Wang F
Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454
[No Abstract] [Full Text] [Related]
11. Clinical values of Ku80 upregulation in superficial esophageal squamous cell carcinoma.
Wang S; Xi J; Lin Z; Hao J; Yao C; Zhan C; Jiang W; Shi Y; Wang Q
Cancer Med; 2018 Apr; 7(4):1006-1018. PubMed ID: 29532618
[TBL] [Abstract][Full Text] [Related]
12. Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.
Liu TT; Yang KX; Yu J; Cao YY; Ren JS; Hao JJ; Pan BQ; Ma S; Yang LY; Cai Y; Wang MR; Zhang Y
J Mol Med (Berl); 2018 Aug; 96(8):807-817. PubMed ID: 29959473
[TBL] [Abstract][Full Text] [Related]
13. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis.
Feng L; Zhao K; Sun L; Yin X; Zhang J; Liu C; Li B
J Transl Med; 2021 Aug; 19(1):367. PubMed ID: 34446045
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor NFE2L3 promotes the proliferation of esophageal squamous cell carcinoma cells and causes radiotherapy resistance by regulating IL-6.
Chen T; Xu B; Chen H; Sun Y; Song J; Sun X; Zhang X; Hua W
Comput Methods Programs Biomed; 2022 Nov; 226():107102. PubMed ID: 36108571
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
16. ERK inhibitor: A candidate enhancing therapeutic effects of conventional chemo-radiotherapy in esophageal squamous cell carcinoma.
Song Y; Cheng Y; Lan T; Bai Z; Liu Y; Bi Z; Alu A; Cheng D; Wei Y; Wei X
Cancer Lett; 2023 Feb; 554():216012. PubMed ID: 36470544
[TBL] [Abstract][Full Text] [Related]
17. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
[TBL] [Abstract][Full Text] [Related]
18. lncRNA BBOX1-AS1 silencing inhibits esophageal squamous cell cancer progression by promoting ferroptosis via miR-513a-3p/SLC7A11 axis.
Pan C; Chen G; Zhao X; Xu X; Liu J
Eur J Pharmacol; 2022 Nov; 934():175317. PubMed ID: 36216119
[TBL] [Abstract][Full Text] [Related]
19. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress.
Liu Z; Gu S; Lu T; Wu K; Li L; Dong C; Zhou Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):144. PubMed ID: 32727517
[TBL] [Abstract][Full Text] [Related]
20. High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Zhou XL; Wang WW; Zhu WG; Yu CH; Tao GZ; Wu QQ; Song YQ; Pan P; Tong YS
Mol Carcinog; 2016 Dec; 55(12):2095-2105. PubMed ID: 26756568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]